Background The aim of this study was to systematically synthesise the global evidence on
the prevalence of persistent symptoms in a general post COVID-19 population. Methods A …

There has been an important change in the clinical characteristics and immune profile of
Coronavirus disease 2019 (COVID‐19) patients during the pandemic thanks to the …

Background Individual case series and cohort studies have reported conflicting results in
people with asthma on the vulnerability to and risk of mortality from coronavirus disease …

Eosinophils are bone marrow-derived granulocytes that, under homeostatic conditions,
account for as much as 1-3% of peripheral blood leukocytes. During inflammation …

The current coronavirus pandemic (COVID-19), caused by SARS-CoV-2, has had
devastating effects on the global health and economic system. The cellular and molecular …

Post-acute sequelae of COVID-19 (PASC) are conditions that occur or remain at least 28
days after SARS-CoV-2 infection. While some risk factors for PASC have been identified …

Abstract The coronavirus disease 2019 (COVID-19) pandemic causes an overwhelming
number of hospitalization and deaths with a significant socioeconomic impact. The vast …

BACKGROUND Prolonged symptoms after SARS-CoV-2 infection are well documented.
However, which factors influence development of long-term symptoms, how symptoms vary …

Autoimmunity may be a complication of SAR-CoV-2 infection. Understanding the
pathogenesis of autoimmune manifestations in COVID-19 might help prevent the incidence …

Introduction There is ongoing debate regarding the role of severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2) infection in asthma exacerbation, and its long-term …